With no way to predict the quantity of life, we can find ways to affect the quality.
Life Biotech’s Scientific Advisory Board are highly qualified medical scientists, medical researchers and doctors, who spend their time working on projects that can impact the quality of life.
– MB, BS (hons) FRACP, FRSANZ
Consultant Cardiologist, emphasis on Preventative Cardiology and Cardiac Imaging, Fellow of the Royal Australian College of Physicians, Member of the Cardiac Society of Australia and New Zealand, Fellow of the Cardiac Society of Australia and New Zealand.
Graduated as a Bachelor of Medicine and Bachelor of Surgery with Honours, Dr Walker adds a list of achievements to his portfolio including being presented at the American College of Cardiology Meeting and performing the first multiplane trans-oesophageal echo-cardiogram in Australia.
Dr Ross Walker graduated from the University of New South Wales in 1979 and commenced specialist training in cardiology. After several years in private practice, Dr Walker opened the Baringa Cardiology Centre in Coffs Harbour. He has since been appointed to the Sydney Adventist Hospital, housing the largest cardiology department in NSW, where he provides a comprehensive service in Echocardiology.
Dr Walker places a particular emphasis on preventative cardiology and works to raise public awareness of heart health. With over 35 years of experience he has the authored several books, including the best seller “Diets Don’t Work”, and lectures extensively on preventative health topics such as “How to Discover Perfect Sleep” and “The Five Point Way to a Healthy Life”. Dr Walker contributes regularly to medical journals and publications, and has appeared on a variety of television programs locally and internationally, as well as hosting regular segments on three radio stations. He has collaborated with international leaders in public health education, such as Dr Robert Atkins and Dr Dean Ornish.
Not only is he a leading cardiologist, Dr Walker is also a professional speaker, presenting at business conventions and retreats. His unique approach to health education entails active patient participation as well as an informed and positive approach. His skills in teaching and communication have made him a highly sought-after speaker around the world.
– Sydney University – Department Of Pharmacy – First Class Honours
Dr Jane Dong graduated with a PhD from Sydney University, Department of Pharmacy of pharmacy. Her research interest was anti-cancer pre-drugs. She has worked at Macquarie University School of biology as a research scientist. She worked here specializing in the research into free radical damage to bio molecules. She has also worked at AGAL federal government laboratory R&D research scientist and now at Life Biotech, in product development and quality control and as Life Biotech’s Director of Manufacturing and Quality Control.
– BMed, MPH, FAFPHM
Dr. Yeqin Zuo is a public health medicine specialist. She has worked in a range of senior positions in cancer control, immunisation and quality use of medicines in government and non-government organisations.
She is a registered medical practitioner in Australia and holds memberships with the royal Australian college of physicians and a fellow of the royal Australian school of public health. She was Head of the NPS evaluation department 2010-2016.
–BS, MEng, MS, PHD, GRACI
Dr. Byron Bian graduated with a Master of Science and Phd degree in Natural Products Chemistry from the University of Newcastle, Australia. Dr Bian and Dr. Ian A. van Altena led the discovery of four new compounds from the Australian Brown Alga Cystophora brownii. The discovery was published in the Australian Journal of Chemistry in 1998. Co-founded Greencare Australia Pty Limited in 2001.
As a natural product chemist, Dr. Bian’s expertise is in isolation, extraction, identification and application of natural solutions. Dr Bian’s core focus and expertise is centered on new clinical trends for complementary medicines, formula designs and TGA compliance.
Dr. Bian is one of the pioneers introducing nicotinamide adenine dinucleotide (NAD+), nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) into the Australia market – including the proposal of the names NAD, NR and NMN to TGA, all of which have been reviewed and agreed upon by the TGA and entered the Australian Approved Name (AAN).
With well over twenty years of experience in research and development within the pharmaceutical industry Dr. Bian extensive knowledge has led to development of several existing patents and further pending patents.
–Dr Eric Chen
Dr Eric Chen currently serves as a shareholder for Life Biotech as well as Director of Ausperfect Development Corporation. While obtaining his PhD in Chemistry from the University of Sydney, specializing in anticancer drug synthesis and initial clinical testing, he was awarded the Australian Scientific Research Council (ARC) scholarship. Further studies included the molecular structure of targeted anticancer drugs in collaboration with the Institute of High Energy Physics, University of Tsukuba, Japan, and SSRL Laboratory of Stanford University, USA.
Dr Eric Chen has held senior positions with chemical, pharmaceutical and health supplement manufacturing companies such as ALPHA LABORATORY, NUPLEX INDUSTRIES and JALCO PHARMACEUTICAL, engaging in the synthesis of pharmaceutical intermediates, the development and quality control of non-prescription health medicine. Dr Eric Chen has also worked extensively in global procurement of chemical raw materials and product management, accumulating a rich experience in the production and management of pharmaceutical products from beginning to end. In 2014, Dr Eric Chen became the founder and director of Ausperfect Development P/L, a company who is involved in the import and export of chemical raw materials and building materials, real estate development and other interests.
